Biogen CEO points to risk in neuroscience as 3 programs cut
Fierce Biotech
by
1y ago
Biogen CEO points to risk in neuroscience as 3 programs cut ..read more
Visit website
AbbVie eyes $60M investment in glaucoma surgical devicemaker
Fierce Biotech
by
1y ago
AbbVie eyes $60M investment in glaucoma surgical devicemaker ..read more
Visit website
Abbott clings to billion-dollar COVID test sales a little longer
Fierce Biotech
by
1y ago
Abbott clings to billion-dollar COVID test sales a little longer ..read more
Visit website
Axel Hoos wants to reinvent small-molecule drugs at Scorpion
Fierce Biotech
by
1y ago
Axel Hoos wants to reinvent small-molecule drugs at Scorpion ..read more
Visit website
Top 10 game-changing biotech layoffs in H1
Fierce Biotech
by
1y ago
Top 10 game-changing biotech layoffs in H1 ..read more
Visit website
Editas' new CEO eyed cash runway, CRISPR tech in job hunt
Fierce Biotech
by
1y ago
Fierce Biotech caught up with Editas' new CEO Gilmore O'Neill and his new CMO to find out what's next for the gene editing biotech ..read more
Visit website
Provention snags $60M to prep for diabetes drug launch
Fierce Biotech
by
1y ago
Provention snags $60M to prep for diabetes drug launch ..read more
Visit website
Ex-Mazor VP faces insider trading suit over Medtronic buyout
Fierce Biotech
by
1y ago
Ex-Mazor VP faces insider trading suit over Medtronic buyout ..read more
Visit website
Sanofi preps hemophilia duo for patients seeking normalcy
Fierce Biotech
by
1y ago
Sanofi preps hemophilia duo for patients seeking normalcy ..read more
Visit website
Decentralized clinical trials, patient experience and more!
Fierce Biotech
by
1y ago
Decentralized clinical trials, patient experience and more ..read more
Visit website

Follow Fierce Biotech on FeedSpot

Continue with Google
Continue with Apple
OR